Targeted oncogenesis reveals a distinct tissue-specific utilization of alternative promoters of the human mineralocorticoid receptor gene in transgenic mice.
The human mineralocorticoid receptor (hMR) is a nuclear receptor mediating aldosterone action, whose expression is driven by two alternative promoters, P1 and P2, flanking the two first 5'-untranslated exons. In vivo characterization of hMR regulatory regions was performed by targeted oncogenesis in mice using P1 or P2 directing expression of the large T antigen of SV40 (TAg). While transgenic P1.TAg founders rapidly developed lethal hibernomas from brown fat, cerebral primitive neuroectodermal tumors and facial leiomyosarcomas occurred in P2.TAg mice. Quantitative analyses of mouse MR (mMR) and transgene expression indicate that P1 promoter was transcriptionally active in all MR-expressing tissues, directing strong TAg expression in testis and salivary glands, moderate in lung, brain, uterus, liver, and heart but, unlike mMR, rather low in colon and kidney. Importantly, the renal transgene expression colocalized with mMR in the distal nephron. In contrast, P2 promoter was approximately 10 times less potent than P1, with no activity in the brain and colon. Several immortalized cell lines were established from both neoplastic and normal tissues of transgenic mice. These cells exhibited differentiated characteristics and maintained MR expression, thus providing useful models for further studies exploring the widespread expression and functions of MR. Our results demonstrate that hMR gene expression in vivo is controlled by complex regulatory mechanisms involving distinct tissue-specific utilization of alternative promoters.
Le Menuet
D
D
INSERM U478, Institut Fédératif de Recherche Cellules Epithéliales, Faculté de Médecine Xavier Bichat, France.
Viengchareun
S
S
Penfornis
P
P
Walker
F
F
Zennaro
M C
MC
Lombès
M
M
D002001:Adipose Tissue, Brown / Q000473:pathology; D000818:Animals; D000957:Antigens, Viral, Tumor / Q000235:genetics; D001921:Brain / Q000473:pathology; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007890:Leiomyosarcoma / Q000235:genetics / Q000473:pathology; D008067:Lipoma / Q000235:genetics / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D008901:Mineralocorticoids / Q000378:metabolism; D017599:Neuroectodermal Tumors / Q000235:genetics / Q000473:pathology; D010641:Phenotype; D011401:Promoter Regions, Genetic; D012333:RNA, Messenger / Q000032:analysis; D018161:Receptors, Mineralocorticoid / Q000235:genetics* / Q000378:metabolism; D015398:Signal Transduction; D013539:Simian virus 40; D014018:Tissue Distribution
D000957:Antigens, Viral, Tumor; D008901:Mineralocorticoids; D012333:RNA, Messenger; D018161:Receptors, Mineralocorticoid